KDM6A and chronic myelomonocytic leukemia: Collectively, these data establish the KDM6A/p‐STAT3 axis as a conserved and pivotal regulatory mechanism governing myeloid differentiation in both human and zebrafish systems, with potential therapeutic implications for CMML.